Showing results (571-580 of 646) with videos related to

Sort By:
Pageof 65
Journal of Clinical Gastroenterology|May 16, 2014
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicitySteven L Flamm, Andrew J Muir, Michael W Fried, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
Pathogen-induced biosynthetic pathways encode defense-related molecules in bread wheatGuy Polturak, Martin Dippe, Michael J Stephenson, et al.
Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
Annals of Hepatology|December 15, 2011
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patientsDavid R Nelson, Stefan Zeuzem, Pietro Andreone, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Genome Biology and Evolution|April 4, 2025
Chromosome-Level Assemblies of the Allohexaploid Genomes of Conyza sumatrensis and Conyza bonariensisAnthony Côrtes Gomes, Jacob Montgomery, André Lucas Simões Araujo, et al.
Scientific Reports|February 18, 2018
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infectionGary P Wang, Norah Terrault, Jacqueline D Reeves, et al.
Obesity Research & Clinical Practice|November 5, 2018
Objectively measured pediatric obesity prevalence using the OneFlorida Clinical Research ConsortiumDominick J Lemas, Michelle I Cardel, Stephanie L Filipp, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare DiseasesAdam Wanner, Stephen C Groft, J Russell Teagarden, et al.
Pageof 65